Eugia SEZ Private Limited – FDA 483, Mar 1, 2019
Aurobindo Pharma Limited, a manufacturer of sterile drug products in Mahabubnagar District, India, received 11 observations during an FDA inspection. The observations highlight significant deficiencies across quality control, manufacturing process validation, complaint investigations, employee training, environmental monitoring in aseptic areas, and laboratory controls. These issues indicate a lack of robust systems to ensure the quality, sterility, and purity of their drug products.
ID · d2dfde51-d58c-479f-b72e-13a40c55f344
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.